The management of gastrointestinal obstructions has been transformed by advances in stenting technology that enable minimally invasive relief across the entire digestive tract, from the esophagus to the colon. Enteral metal stents have emerged as versatile tools in this evolution, offering durable, effective solutions for obstructions at various anatomical sites. The Medical Metal Enteral Stent Market reflects this expanding role, with the market valued at USD 800 million in 2025 and projected to reach USD 1.5 billion by 2035, representing a compound annual growth rate of 5.9%. This growth trajectory underscores the expanding applications of metal stents across gastrointestinal care.

The Expanding Role of Digestive Tract Stenting

Digestive tract stenting has become increasingly important across the gastrointestinal system, enabling the relief of obstructions in the esophagus, stomach, colon, and biliary tract. The development of versatile metal stents has expanded the range of conditions that can be treated endoscopically, improving outcomes for patients with diverse gastrointestinal pathologies. The application segment of the medical metal enteral stent market reveals the diverse anatomical locations in which these stents are employed.

Esophageal stenting currently dominates the market, boasting a valuation of USD 280 million in 2024 and projected to grow to USD 540 million by 2035, addressing complex conditions such as esophageal strictures and malignancies. Gastric stenting is expected to experience strong growth due to its vital role in managing gastric outlet obstruction, enhancing the quality of life for patients with this condition. Colonic stenting shows a trend of steady expansion as it provides effective solutions for bowel obstructions, enabling minimally invasive treatment pathways. Biliary stenting is also gaining attention, reflecting a gradual increase as it addresses biliary obstructions with effective interventions.

Enteral Metal Stents in Esophageal and Gastric Applications

Enteral metal stents have become essential for managing esophageal and gastric obstructions, providing durable, effective relief for patients with strictures, tumors, and other pathologies. Esophageal stenting currently represents the largest application segment, driven by the high prevalence of esophageal cancer and strictures, and the need for effective dysphagia palliation. Self-expanding metal stents are preferred for esophageal applications due to their ease of placement and ability to maintain luminal patency.

Gastric stenting addresses gastric outlet obstruction, a condition that can result from gastric cancer, pancreatic cancer, or other malignancies. Metal stents provide effective relief of obstructive symptoms, enabling patients to resume oral intake and improving quality of life. The development of stents with improved conformability and reduced migration rates has enhanced outcomes in gastric applications, contributing to the growth of this segment.

Colonic and Biliary Stenting Applications

Colonic stenting has emerged as an effective alternative to emergency surgery for patients with malignant colonic obstruction, enabling elective surgical resection after decompression. The use of metal stents as a bridge to surgery has been associated with reduced morbidity and improved outcomes compared to emergency surgery. Colonic stenting shows a trend of steady expansion as it provides effective solutions for bowel obstructions, enabling minimally invasive treatment pathways.

Biliary stenting addresses obstructive jaundice caused by malignant or benign biliary strictures, providing effective drainage and improving quality of life. Metal stents offer advantages over plastic stents in terms of longer patency and reduced need for repeat procedures. The development of covered metal stents has reduced the risk of tumor ingrowth, further improving outcomes in biliary applications.

Technological Advancements and Market Trends

Recent technological innovations are transforming the medical metal enteral stent market, enhancing the performance, safety, and usability of these essential devices. Advancements in material science, such as the development of biocompatible and corrosion-resistant alloys, are enhancing the efficacy and longevity of metal enteral stents. The development of drug-eluting stents and bioresorbable materials represents a frontier of innovation.

Recent industry developments reflect the dynamic nature of the market. Boston Scientific announced in January 2025 a strategic partnership with Olympus Corporation to co-develop and commercialize next-generation metal enteral stents and delivery systems. Terumo Corporation completed the acquisition of EnteralTech in October 2024 to expand its portfolio of self-expanding metal stents. Cook Medical secured in May 2025 a major contract win with a leading U.S. health system to supply a comprehensive range of metal enteral stents.

Regional Market Dynamics

North America leads the medical metal enteral stent market, demonstrating significant share due to advanced healthcare infrastructure and a growing patient pool. Europe is also expected to hold a considerable segment, driven by rising awareness and technological advancements. The Asia-Pacific region is projected to exhibit robust growth, fueled by increasing healthcare expenditure and demand for minimally invasive procedures.

Future Outlook

The future of the medical metal enteral stent market appears promising, with continued growth driven by technological advancements in stent design, increasing prevalence of gastrointestinal disorders, and rising demand for minimally invasive procedures. As the Medical Metal Enteral Stent Market continues its growth trajectory, digestive tract stenting and enteral metal stents will play an increasingly vital role in improving outcomes for patients with gastrointestinal obstructions across diverse anatomical locations.